The Company has granted stock options, restricted share units (“RSUs”) and deferred share units (“DSUs”) to employees and non-employee directors under the 2020 Omnibus Equity Incentive Plan dated March 29, 2020 (the “2020 Omnibus Plan”) and the DSU Plan dated August 10, 2019 (the “DSU Plan”).

The following table summarizes the total share-based compensation expense associated with the Company’s stock options, RSUs and DSUs for the three and six months ended June 30, 2026 and 2025:


	Three months ended June 30,				Six months ended June 30,
	2026		2025		2026		2025
Stock options	$	17	$	79	$	35	$	154
RSUs	1,319		1,302		2,657		3,315
DSUs	221		—		178		—
Total share-based compensation	$	1,557	$	1,381	$	2,870	$	3,469

Share-based compensation for the three and six months ended June 30, 2026 included a loss of $221 and a loss of $178, respectively, associated with the revaluation of the Company’s DSUs. For the three and six months ended June 30, 2025, a loss of $7 and a gain of $109, respectively, was included in revaluation of financial instruments in the Company’s condensed consolidated statements of net income (loss) and comprehensive income (loss), related to the revaluation of DSUs.

Vesting conditions for grants of options are determined by the Compensation Committee of the Board. The typical vesting for stock option grants made under the 2020 Omnibus Plan is annual vesting over three to five years with a maximum term of ten years. The 2020 Omnibus Plan does not authorize grants of options with an exercise price below fair market value.

The following is a summary of the changes in stock options for the six months ended June 30, 2026 and 2025:


	Weighted-average exercise price (C$) (i)		Number of options	Weighted-average remaining contractual term (years)
Balance as of December 31, 2025	$	5.68	588,317	2.48



Balance as of June 30, 2026	$	5.68	588,317	1.99
Exercisable as of June 30, 2026	$	5.85	553,007	1.88


	Weighted-average exercise price (C$) (i)		Number of options	Weighted-average remaining contractual term (years)
Balance as of December 31, 2024	$	5.63	717,264	3.65



Balance as of June 30, 2025	$	5.63	717,264	2.51
Exercisable as of June 30, 2025	$	5.98	634,875	2.22

(i)The weighted-average exercise price reflects the conversion of foreign currency-denominated stock options translated into C$ using the average foreign exchange rate as of the date of issuance.


	As of June 30, 2026	As of December 31, 2025
2020 Omnibus Plan	588,317	588,317


Total stock options outstanding	588,317	588,317

The following is a summary of the changes in RSUs for the six months ended June 30, 2026 and 2025:


	Weighted-average grant date fair value (C$)(ii)		Number of RSUs
Balance as of December 31, 2025	$	2.85	5,385,106
Granted(i)	3.56		2,043,367
Vested and issued	2.72		(2,170,748)
Cancellation and forfeitures	3.08		(124,144)
Balance as of June 30, 2026	$	3.13	5,133,581


	Weighted-average grant date fair value (C$)(ii)		Number of RSUs
Balance as of December 31, 2024	$	3.50	8,382,213
Granted(i)	2.74		2,633,793
Vested and issued	3.91		(4,844,056)
Cancellation and forfeitures	3.34		(508,967)
Balance as of June 30, 2025	$	2.81	5,662,983

(i)RSUs granted in the period vest annually in equal installments over a three-year period from the grant date. All RSUs are subject to such holder’s continued employment through each vesting date. The vesting of such RSUs is not subject to the achievement of any performance criteria.

(ii)The weighted-average grant date fair value reflects the conversion of foreign currency-denominated RSUs translated into C$ using the foreign exchange rate as of the date of issuance.

The following is a summary of the changes in DSUs for the six months ended June 30, 2026 and 2025:


	Financial liability		Number of DSUs
Balance as of December 31, 2025	$	1,993	758,499


Loss on revaluation	178		—
Foreign exchange effect	(77)		—
Balance as of June 30, 2026	$	2,094	758,499


	Financial liability		Number of DSUs
Balance as of December 31, 2024	$	1,129	560,261


Gain on revaluation	(109)		—
Foreign exchange effect	55		—
Balance as of June 30, 2025	$	1,075	560,261